A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

NCT07645924 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1800

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Elismetrep
DRUG: Placebo

Sponsor

Kallyope Inc.